ESC 365 - Efficacy of additional medical therapies in patients with heart failure, a reduced ejection fraction and chronic kidney disease already receiving neurohormonal inhibitors: a network meta-analysis

HFA Premium Access

Efficacy of additional medical therapies in patients with heart failure, a reduced ejection fraction and chronic kidney disease already receiving neurohormonal inhibitors: a network meta-analysis

Session: Young Investigator Award: clinical research

Topic: Pharmacotherapy

Speaker: Doctor V. De Marzo (Genoa, IT)

Event: Heart Failure 2021 Online Congress

Presentation

About the speaker

Doctor Vincenzo De Marzo

San Martino Hospital, Genoa (Italy)

0 follower

3 more presentations in this session

Effect of SGLT2 inhibitors on diastolic function in patients with non-obstructive hypertrophic cardiomyopathy

Speaker: Doctor M. Subramanian (Hyderabad, IN)

Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy

Speaker: Doctor R. Rettl (Vienna, AT)

Target dose of heart failure medications is associated with better mortality/morbidity: data from the Swedish Heart Failure Registry

Speaker: Mr D. Rodolico (Stockholm, SE)

Access the full session

Young Investigator Award: clinical research

Speakers: Doctor V. De Marzo, Doctor M. Subramanian, Doctor R. Rettl, Mr D. Rodolico

About the event

Heart Failure 2021 Online Congress

29 June - 1 July 2021

Sessions Presentations

Congress

Related content

ESC Premium Access

New and upcoming technology for heart failure management.

23 October 2021

ESC Premium Access

A patient with NSTEMI and atrial fibrillation: how to implement the guidelines and take-home message.

27 August 2021

ESC Premium Access

An asymptomatic patient with positive treadmill test during screening for life insurance and significant proximal LAD disease in coronary CT angiography: how to implement the guidelines and take-home message.

27 August 2021

This platform is supported by